Modern External-Beam Radiation Therapy for Prostate Cancer: How and When?

Jemal, 2007, Cancer statistics, 2007, CA Cancer J Clin, 57, 43, 10.3322/canjclin.57.1.43 Del Regato, 1967, Radiotherapy in the conservative treatment of operable and locally inoperable carcinoma of the prostate, Radiology, 88, 761, 10.1148/88.4.761 Bagshaw, 1965, Linear accelerator supervoltage radiotherapy. VII. Carcinoma of the prostate, Radiology, 85, 121, 10.1148/85.1.121 Aus, 2005, EAU guidelines on prostate cancer, Eur Urol, 48, 546, 10.1016/j.eururo.2005.06.001 Leibel, 2003, Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer, Semin Oncol, 30, 596, 10.1016/S0093-7754(03)00354-3 Debois, 1999, The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer, Int J Radiat Oncol Biol Phys, 45, 857, 10.1016/S0360-3016(99)00288-6 Sannazzari, 2002, CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer, Br J Radiol, 75, 603, 10.1259/bjr.75.895.750603 Ling, 2000, Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality, Int J Radiat Oncol Biol Phys, 47, 551, 10.1016/S0360-3016(00)00467-3 Brahme, 1982, Solution of an integral equation encountered in rotation therapy, Phys Med Biol, 27, 1221, 10.1088/0031-9155/27/10/002 Zelefsky, 1998, Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer, Int J Radiat Oncol Biol Phys, 41, 491, 10.1016/S0360-3016(98)00091-1 Zelefsky, 2002, High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients, Int J Radiat Oncol Biol Phys, 53, 1111, 10.1016/S0360-3016(02)02857-2 Zietman, 2005, Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial, JAMA, 294, 1233, 10.1001/jama.294.10.1233 Webb, 2006, Innovative techniques in radiation therapy: editorial, overview, and crystal ball gaze to the future, Semin Radiat Oncol, 16, 193, 10.1016/j.semradonc.2006.04.001 Hong, 2005, Intensity-modulated radiation therapy: emerging cancer treatment technology, Br J Cancer, 92, 1819, 10.1038/sj.bjc.6602577 Valicenti, 2003, Radiation therapy after radical prostatectomy: a review of the issues and options, Semin Radiat Oncol, 13, 130, 10.1016/S1053-4296(03)70006-X Kattan, 1998, A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer, J Natl Cancer Inst, 90, 766, 10.1093/jnci/90.10.766 Lowe, 1997, Disease recurrence and progression in untreated pathologic stage T3 prostate cancer: selecting the patient for adjuvant therapy, J Urol, 158, 1452, 10.1016/S0022-5347(01)64240-X Kattan, 1999, Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer, J Clin Oncol, 17, 1499, 10.1200/JCO.1999.17.5.1499 Paulson, 1990, Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule, J Urol, 143, 1178, 10.1016/S0022-5347(17)40219-9 Valicenti, 1999, The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis, Int J Radiat Oncol Biol Phys, 45, 53, 10.1016/S0360-3016(99)00169-8 Leibovich, 2000, Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin, J Urol, 163, 1178, 10.1016/S0022-5347(05)67717-8 McCarthy, 1994, Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment, J Urol, 151, 1575, 10.1016/S0022-5347(17)35305-3 Bolla, 2005, Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911), Lancet, 366, 572, 10.1016/S0140-6736(05)67101-2 Thompson, 2006, Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial, JAMA, 296, 2329, 10.1001/jama.296.19.2329 Wiegel, 2005, Phase III results of adjuvant radiotherapy (RT) versus “wait and see” (WS) in patients with pT3 prostate cancer following radical prostatectomy (RP)(ARO 96-02/AUO AP 09/95), J Clin Oncol, 23, 16S Stephenson, 2007, Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy, J Clin Oncol, 25, 2035, 10.1200/JCO.2006.08.9607 http://www.ahcpr.gov. Accessed 2007. Zietman, 1997, Androgen deprivation and radiation therapy: sequencing studies using the Shionogi in vivo tumor system, Int J Radiat Oncol Biol Phys, 38, 1067, 10.1016/S0360-3016(97)00309-X Joon, 1997, Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation, Int J Radiat Oncol Biol Phys, 38, 1071, 10.1016/S0360-3016(97)00303-9 Pilepich, 2005, Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85-31, Int J Radiat Oncol Biol Phys, 61, 1285, 10.1016/j.ijrobp.2004.08.047 Bolla, 2002, Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial, Lancet, 360, 103, 10.1016/S0140-6736(02)09408-4 Neymark, 2002, Estimating survival gain for economic evaluations with survival time as principal endpoint: a cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer, Health Econ, 11, 233, 10.1002/hec.662 Hanks, 2003, Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02, J Clin Oncol, 21, 3972, 10.1200/JCO.2003.11.023 Roach, 2003, Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413, J Clin Oncol, 21, 1904, 10.1200/JCO.2003.05.004 Bolla, 2007, Concomitant and adjuvant androgen deprivation (ADT) with external beam irradiation (RT) for locally advanced prostate cancer: 6 months versus 3 years ADT—results of the randomized EORTC phase III trial 22961, J Clin Oncol, 25, 238S